VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Share Price, News & Analysis

Company Overview

Providing investors access to opportunities that will strengthen their portfolios is VanEck’s guiding principle. Through forward-looking, intelligently designed active and ETF solutions, we offer value-added exposures to emerging industries, asset classes and markets as well as differentiated approaches to traditional strategies. We think beyond the financial markets to identify the trends—including economic, technological, political and social—that we believe will fuel investable opportunities. VanEck was one of the first U.S. asset managers to offer investors access to international markets and recognized early the transformative potential of gold investing, emerging markets and ETFs. Today, our firm’s capabilities range from core investment opportunities to more specialized exposures to enhance portfolio diversification.

Key Stats

• Today's Range: 13.15 to 13.24
• 50-Day Range: 13.14 to 15.48
• 52-Week Range: 13.14 to 16.50
• Volume: 752 shs
• Average Volume: 525 shs
• Market Capitalization: £189.87 million
• P/E Ratio: N/A
• Dividend Yield: 2.25%
• Price Target: N/A
• Consensus Rating: N/A

CYBG Stock Analysis - Frequently Asked Questions

How have CYBG shares performed this year?

VanEck Bionic Engineering UCITS ETF A Acc's stock was trading at GBX 15.67 at the beginning of the year. Since then, CYBG stock has decreased by 15.5% and is now trading at GBX 13.24.

How do I buy shares of VanEck Bionic Engineering UCITS ETF A Acc?

Shares of CYBG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of VanEck Bionic Engineering UCITS ETF A Acc own?

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Bionic Engineering UCITS ETF A Acc investors own include Virgin Money UK (VMUK), G-III Apparel Group (GIII), Alphabet (GOOG), Ionis Pharmaceuticals (IONS), Svenska Handelsbanken Ab Publ (SVNLY) and Western Union (WU).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Finance
• Industry: Banks - Regional - Europe
• Sub-Industry: N/A
• Current Symbol: LON:CYBG
• CIK: N/A
• Web: www.cybg.com
• Phone: +44-141-2324763
• Fax: N/A
• Employees: 5,762
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 0.00
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: £1.24 billion
• Price / Sales: 0.15
• Cash Flow: GBX 99 per share
• Price / Cash Flow: 0.13
• Book Value: GBX 355.10 per share
• Price / Book: 0.04

Miscellaneous

• Outstanding Shares: 1,434,489,984
• Free Float: N/A
• Market Cap: £189.87 million
• Optionable: Not Optionable
• Beta: N/A